Australia markets close in 3 hours 33 minutes

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.50-0.35 (-2.21%)
At close: 04:00PM EDT
16.27 +0.77 (+4.97%)
After hours: 05:57PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
88,494
84,721
60,397
47,826
46,787
Selling general and administrative
46,336
46,537
31,502
19,653
16,096
Total operating expenses
134,830
131,258
91,899
67,479
62,883
Operating income or loss
-134,830
-131,258
-91,899
-67,479
-62,883
Interest expense
0
414
578
580
970
Total other income/expenses net
-
792
51
245
237
Income before tax
-133,331
-130,466
-89,625
-63,140
-60,447
Income from continuing operations
-133,331
-130,466
-89,625
-63,140
-60,447
Net income
-133,331
-130,466
-89,625
-63,140
-60,447
Net income available to common shareholders
-133,331
-130,466
-89,625
-63,140
-60,447
Basic EPS
-
-1.97
-1.69
-1.51
-1.72
Diluted EPS
-
-1.97
-1.69
-1.51
-1.72
Basic average shares
-
66,352
53,077
41,946
35,191
Diluted average shares
-
66,352
53,077
41,946
35,191
EBITDA
-
-129,494
-88,853
-62,560
-59,467